Similar Articles
1011 Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
1012 Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
1013 Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?
1014 Hepatocellular carcinoma: Where are we?
1015 Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan
1016 Molecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?
1017 Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art
1018 Hepatocellular carcinoma and hepatitis B surface protein
1019 Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
1020 Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA